Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a
Journal
Acta neurologica Taiwanica
Journal Volume
29(3)
Pages
90-94
Date Issued
2020
Author(s)
Abstract
A case report with a review of the current literature concerning cutaneous necrosis has occasionally been reported in interferon therapy. We report a 19-year-old woman diagnosed multiple sclerosis for three years. She selfinjected the standard dose of recombinant interferonβ-1a (12 million units) subcutaneously three times a week. Severe necrotizing cutaneous reactions over abdomen Happened and she must receive parental antibiotics and surgical debridement. Our observation emphasizes the importance of educating patients on the proper selfadministration of subcutaneous injections of interferon β.
SDGs
Publisher
NLM (Medline)
Type
journal article